Ryszard Czepko

722 total citations
51 papers, 446 citations indexed

About

Ryszard Czepko is a scholar working on Neurology, Genetics and Cellular and Molecular Neuroscience. According to data from OpenAlex, Ryszard Czepko has authored 51 papers receiving a total of 446 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Neurology, 11 papers in Genetics and 11 papers in Cellular and Molecular Neuroscience. Recurrent topics in Ryszard Czepko's work include Cerebrospinal fluid and hydrocephalus (11 papers), Glioma Diagnosis and Treatment (10 papers) and Pituitary Gland Disorders and Treatments (10 papers). Ryszard Czepko is often cited by papers focused on Cerebrospinal fluid and hydrocephalus (11 papers), Glioma Diagnosis and Treatment (10 papers) and Pituitary Gland Disorders and Treatments (10 papers). Ryszard Czepko collaborates with scholars based in Poland, United States and Canada. Ryszard Czepko's co-authors include Daniel Roy, Jean Raymond, J Hardy, Witold Libionka, Tomasz Dziedzic, Andrzej Szczudlik, Joanna Pera, Denise A. Figlewicz, Mariusz Banach and Krzysztof Stachura and has published in prestigious journals such as Stroke, International Journal of Molecular Sciences and Journal of neurosurgery.

In The Last Decade

Ryszard Czepko

46 papers receiving 436 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ryszard Czepko Poland 11 198 128 117 94 77 51 446
Dieter-Karsten Böker Germany 13 234 1.2× 105 0.8× 240 2.1× 98 1.0× 91 1.2× 28 565
Yasuo Sasagawa Japan 13 148 0.7× 198 1.5× 162 1.4× 144 1.5× 78 1.0× 71 517
Fuminari Komatsu Japan 16 188 0.9× 123 1.0× 202 1.7× 181 1.9× 48 0.6× 59 533
Armando Basso Argentina 12 252 1.3× 101 0.8× 153 1.3× 180 1.9× 104 1.4× 28 466
Tetsuo Hashiba Japan 13 191 1.0× 94 0.7× 80 0.7× 194 2.1× 46 0.6× 23 440
Shamik Chakraborty United States 12 169 0.9× 76 0.6× 135 1.2× 143 1.5× 82 1.1× 29 478
Seung-Ho Yang South Korea 14 128 0.6× 154 1.2× 111 0.9× 62 0.7× 67 0.9× 45 518
Hasan A. Zaidi United States 15 191 1.0× 143 1.1× 273 2.3× 210 2.2× 83 1.1× 30 659
Kaoru Kurisu Japan 12 215 1.1× 133 1.0× 187 1.6× 216 2.3× 55 0.7× 38 580
Yosef Laviv Israel 12 194 1.0× 68 0.5× 138 1.2× 145 1.5× 29 0.4× 46 538

Countries citing papers authored by Ryszard Czepko

Since Specialization
Citations

This map shows the geographic impact of Ryszard Czepko's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ryszard Czepko with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ryszard Czepko more than expected).

Fields of papers citing papers by Ryszard Czepko

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ryszard Czepko. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ryszard Czepko. The network helps show where Ryszard Czepko may publish in the future.

Co-authorship network of co-authors of Ryszard Czepko

This figure shows the co-authorship network connecting the top 25 collaborators of Ryszard Czepko. A scholar is included among the top collaborators of Ryszard Czepko based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ryszard Czepko. Ryszard Czepko is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
3.
Ciechomska, Iwona A., Kamil Wojnicki, Bartosz Wojtaś, et al.. (2023). Exploring Novel Therapeutic Opportunities for Glioblastoma Using Patient-Derived Cell Cultures. Cancers. 15(5). 1562–1562. 12 indexed citations
4.
Gielniewski, Bartłomiej, Marta Maleszewska, Sylwia Król, et al.. (2020). Identification of the immune gene expression signature associated with recurrence of high-grade gliomas. Journal of Molecular Medicine. 99(2). 241–255. 9 indexed citations
5.
Czepko, Ryszard, et al.. (2018). Effect of Social Factors on Surgical Outcomes in Cervical Disc Disease. Anesthesiology and Pain Medicine. 8(6). e84140–e84140. 3 indexed citations
6.
Giannopoulos, Krzysztof, Krzysztof Jamroziak, Lidia Usnarska‐Zubkiewicz, et al.. (2018). Zalecenia Polskiej Grupy Szpiczakowej dotyczące rozpoznawania i leczenia szpiczaka plazmocytowego oraz innych dyskrazji plazmocytowych na rok 2018/2019. Acta Haematologica Polonica. 49(4). 157–206. 10 indexed citations
8.
Jurczyszyn, Artur, et al.. (2015). Percutaneous Vertebroplasty for Pathological Vertebral Compression Fractures Secondary to Multiple Myeloma – Medium-Term and Long-Term Assessment of Pain Relief and Quality of Life. Advances in Clinical and Experimental Medicine. 24(4). 651–656. 10 indexed citations
9.
Stachura, Krzysztof & Ryszard Czepko. (2007). [Results of neuroendoscopic treatment of arachnoid cysts in adults].. PubMed. 40(5). 391–6. 3 indexed citations
10.
Gołkowski, Filip, Małgorzata Trofimiuk, Ryszard Czepko, et al.. (2007). Two Rare Cases of Pituitary Metastases from Breast and Kidney Cancers. Experimental and Clinical Endocrinology & Diabetes. 115(8). 537–540. 10 indexed citations
11.
Czepko, Ryszard & Borys Kwinta. (2006). [The use of TachoComb for the rhinorrhea repair in pituitary transsphenoidal surgery].. PubMed. 36(2). 3–9. 1 indexed citations
12.
Pera, Joanna, Agnieszka Słowik, Tomasz Dziedzic, et al.. (2005). Endoglin gene insertion polymorphism not associated with aneurysmal subarachnoid hemorrhage. Journal of neurosurgery. 102(5). 879–881. 8 indexed citations
13.
Stachura, Krzysztof, Witold Libionka, & Ryszard Czepko. (2005). [The use of neuroendoscopy in the treatment of intraventricular and paraventricular brain tumors].. PubMed. 39(2). 101–7. 6 indexed citations
14.
Czepko, Ryszard & Borys Kwinta. (2005). [The evaluation of early and late results of using Codubix cranial prosthesis].. PubMed. 35(2). 33–40. 2 indexed citations
15.
Czepko, Ryszard, et al.. (2005). [Mechanically detachable coils in the treatment of posterior circulation aneurysms: a comparison with surgical repair].. PubMed. 62(1). 24–8.
16.
Cieślicki, Krzysztof & Ryszard Czepko. (2004). [Optimal use of the lumbar infusion test in patients with communicating hydrocephalus. Theoretical considerations in comparison to clinical observations].. PubMed. 38(3). 189–95. 4 indexed citations
17.
Słowik, Agnieszka, Joanna Pera, Tomasz Dziedzic, et al.. (2004). II Genotype of the Angiotensin-Converting Enzyme Gene Increases the Risk for Subarachnoid Hemorrhage From Ruptured Aneurysm. Stroke. 35(7). 1594–1597. 41 indexed citations
18.
Danilewicz, Marian, et al.. (2000). [Intradural clivus chordoma: surgical treatment with no tumor regrowth 12 years after surgery].. PubMed. 57(3). 178–80. 9 indexed citations
19.
Czepko, Ryszard. (1999). [The clinical value of B waves in the cerebrospinal fluid pressure curve during the lumbar infusion test of patients with hydrocephalus].. PubMed. 56(9). 568–75. 1 indexed citations
20.
Czepko, Ryszard, et al.. (1990). [Immediate and late results of surgical treatment of hydrocephalus after subarachnoid hemorrhage].. PubMed. 47(10). 678–81. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026